| scholarly article | Q13442814 |
| P2093 | author name string | Macklem PT | |
| Martin JG | |||
| Gibbons L | |||
| Shapiro SH | |||
| Gray-Donald K | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chronic obstructive pulmonary disease | Q199804 |
| P304 | page(s) | 961-966 | |
| P577 | publication date | 1996-03-01 | |
| P1433 | published in | American Journal of Respiratory and Critical Care Medicine | Q4744267 |
| P1476 | title | Nutritional status and mortality in chronic obstructive pulmonary disease | |
| P478 | volume | 153 |
| Q37021361 | A prediction model for COPD readmissions: catching up, catching our breath, and improving a national problem |
| Q34128930 | A validated disease specific prediction equation for resting metabolic rate in underweight patients with COPD |
| Q37110291 | Activation of the ubiquitin-proteasome pathway in the diaphragm in chronic obstructive pulmonary disease |
| Q37236723 | Anabolic steroids in COPD: a review and preliminary results of a randomized trial |
| Q22306060 | Animal Models of Cigarette Smoke-Induced COPD* |
| Q48610174 | Apoptosis and Id2 expression in diaphragm and soleus muscle from the emphysematous hamster |
| Q85072728 | Assessment of nutritional status and body composition in patients with COPD: comparison of several methods |
| Q34626048 | Association of lung function with coronary heart disease and cardiovascular disease outcomes in elderly: the Rancho Bernardo study |
| Q46550797 | Associations of muscle depletion with health status. Another gender difference in COPD? |
| Q47693776 | BMI and oral glucocorticoids as predictors of prognosis in COPD patients on long-term oxygen therapy |
| Q36730719 | Behavioral medicine approaches to chronic obstructive pulmonary disease |
| Q35633624 | Body composition and functional limitation in COPD. |
| Q34399525 | Body mass index and mortality in chronic obstructive pulmonary disease: a meta-analysis |
| Q47665346 | Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study |
| Q42398899 | British Thoracic Society guideline on pulmonary rehabilitation in adults: does objectivity have a sliding scale? |
| Q38813062 | COPD: Mortality and Readmissions in Relation to Number of Admissions with Noninvasive Ventilation |
| Q37856579 | COPD: a multifactorial systemic disease |
| Q35075588 | Chronic obstructive pulmonary disease . 7: Management of COPD |
| Q43253464 | Chronic obstructive pulmonary disease in UK primary care: incidence and risk factors |
| Q38864872 | Chronic obstructive pulmonary disease phenotypes and balance impairment |
| Q64319779 | Cluster analysis identifying patients with COPD at high risk of 2-year all-cause mortality |
| Q37103715 | Comorbidities in chronic obstructive pulmonary disease |
| Q34606406 | Comparative assessment of the quadriceps and the diaphragm in patients with COPD. |
| Q37298926 | Determinants of health related quality of life in a sample of patients with chronic obstructive pulmonary disease in Nigeria using the St. George's respiratory questionnaire |
| Q28066535 | Diaphragm Muscle Adaptation to Sustained Hypoxia: Lessons from Animal Models with Relevance to High Altitude and Chronic Respiratory Diseases |
| Q37064535 | Diaphragm adaptations in patients with COPD. |
| Q37282789 | Diaphragm dysfunction in chronic obstructive pulmonary disease. |
| Q36782640 | Diaphragm muscle fiber dysfunction in chronic obstructive pulmonary disease: toward a pathophysiological concept |
| Q51681547 | Differential sensitivity of oxidative and glycolytic muscles to hypoxia-induced muscle atrophy. |
| Q44673394 | Effect of inflammation on handgrip strength in the non-critically ill is independent from age, gender and body composition |
| Q77330922 | Effect of nutritional status on use of health care resources by patients with chronic disease living in the community |
| Q37464686 | Effects of anabolic steroids on chronic obstructive pulmonary disease: a meta-analysis of randomised controlled trials |
| Q45006403 | Effects of home pulmonary rehabilitation in patients with chronic respiratory failure and nutritional depletion |
| Q44991387 | Elevated plasma ghrelin level in underweight patients with chronic obstructive pulmonary disease |
| Q51555161 | Energy expenditure in chronic obstructive pulmonary disease-evaluation of simple measures. |
| Q55027289 | Exercise response to oxygen supplementation is not associated with survival in hypoxemic patients with obstructive lung disease. |
| Q36669477 | Factors associated with outcomes of acute exacerbations of chronic obstructive pulmonary disease |
| Q34697244 | Ghrelin and its potential in the treatment of eating/wasting disorders and cachexia |
| Q57091510 | Hypoxia impairs adaptation of skeletal muscle protein turnover- and AMPK signaling during fasting-induced muscle atrophy |
| Q34083585 | Impact of obesity on the clinical profile of a population-based sample with chronic obstructive pulmonary disease |
| Q48328828 | Inability of single resting arterial blood gas to predict significant hypoxaemia in chronic obstructive pulmonary disease |
| Q82322357 | Inspiratory muscle weakness is associated with autonomic cardiovascular dysfunction in patients with type 2 diabetes mellitus |
| Q93911229 | International guidelines for the selection of lung transplant candidates. The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society |
| Q46029696 | L-2-Oxothiazolidine-4-carboxylate reverses glutathione oxidation and delays fatigue of skeletal muscle in vitro. |
| Q46259496 | Levosimendan enhances force generation of diaphragm muscle from patients with chronic obstructive pulmonary disease |
| Q43972063 | Long term survival in chronic obstructive pulmonary disease after ventilation in intensive care |
| Q35941658 | Longitudinal Forced Vital Capacity Monitoring as a Prognostic Adjunct after Lung Transplantation. |
| Q37137688 | Lung function indices for predicting mortality in COPD. |
| Q34149601 | Lung transplantation for chronic obstructive pulmonary disease |
| Q35293795 | Lung transplantation. Recipient selection |
| Q35879714 | Management of severe COPD. |
| Q37704865 | Maximum inspiratory pressure as a clinically meaningful trial endpoint for neuromuscular diseases: a comprehensive review of the literature |
| Q38835917 | Meeting the challenge of COPD care delivery in the USA: a multiprovider perspective |
| Q28390165 | Metabolic syndrome biomarkers in prediction of lung function impairment |
| Q36669455 | Minimal clinically important differences in COPD: body mass index and muscle strength |
| Q37790366 | Mortality in COPD: causes, risk factors, and prevention. |
| Q26865732 | Muscle function in COPD: a complex interplay |
| Q47177654 | Muscle mass, not body weight, predicts outcome in patients with chronic obstructive pulmonary disease |
| Q41611500 | Natural history and prognosis of advanced lung disease |
| Q93048363 | Normative Data on Grip Strength in a Population-Based Study with Adjusting Confounding Factors: Sixth Korea National Health and Nutrition Examination Survey (2014-2015) |
| Q34149572 | Nutritional abnormalities and supplementation in chronic obstructive pulmonary disease |
| Q37103694 | Nutritional aspects of chronic obstructive pulmonary disease |
| Q51763281 | Nutritional depletion and its relationship to respiratory impairment in patients with chronic respiratory failure due to COPD or restrictive thoracic diseases. |
| Q24202330 | Nutritional supplementation for stable chronic obstructive pulmonary disease |
| Q24244188 | Nutritional supplementation for stable chronic obstructive pulmonary disease |
| Q33978274 | Nutritional supplementation in stable chronic obstructive pulmonary disease |
| Q43664449 | Overweight and obesity may lead to under-diagnosis of airflow limitation: findings from the Copenhagen City Heart Study. |
| Q37960814 | Palliative care concepts in respiratory disease |
| Q35816314 | Palliative care in the management of chronic obstructive pulmonary disease |
| Q34700758 | Paradoxical association between body mass index and in-hospital mortality in elderly patients with chronic obstructive pulmonary disease in Japan |
| Q36037006 | Personalized pulmonary rehabilitation and occupational therapy based on cardiopulmonary exercise testing for patients with advanced chronic obstructive pulmonary disease |
| Q47202721 | Plasma ghrelin levels and weight loss in Chinese Uygur patients with chronic obstructive pulmonary disease |
| Q33706205 | Plasma orexin-A and ghrelin levels in patients with chronic obstructive pulmonary disease: Interaction with nutritional status and body composition |
| Q41915879 | Prediction of outcome and prognosis of patients on mechanical ventilation using body mass index, SOFA score, C-Reactive protein, and serum albumin |
| Q36902669 | Predictors for mortality from respiratory failure in a general population |
| Q50778308 | Predictors of 6-month mortality in elderly patients with mild chronic obstructive pulmonary disease discharged from a medical ward after acute nonacidotic exacerbation. |
| Q46950827 | Predictors of body mass index in patients with moderate to severe emphysema |
| Q37144509 | Predictors of mortality in patients with emphysema and severe airflow obstruction |
| Q35019225 | Prevalence and global initiative for chronic obstructive lung disease group distribution of chronic obstructive pulmonary disease detected by preoperative pulmonary function test |
| Q40506151 | Prevalence and outcomes of diaphragmatic dysfunction assessed by ultrasound technology during acute exacerbation of COPD: A pilot study. |
| Q27339178 | Prevalence of and risk factors for postoperative pulmonary complications after lung cancer surgery in patients with early-stage COPD. |
| Q51768702 | Proteasome inhibition improves diaphragm function in an animal model for COPD. |
| Q43588205 | Protein-energy undernutrition and the risk of mortality within six years of hospital discharge |
| Q34774443 | Pulmonary cachexia |
| Q39216001 | Pulmonary rehabilitation: the reference therapy for undernourished patients with chronic obstructive pulmonary disease |
| Q53559257 | Quality of life in elderly patients with COPD: measurement and predictive factors. |
| Q51564092 | Redox Remodeling Is Pivotal in Murine Diaphragm Muscle Adaptation to Chronic Sustained Hypoxia. |
| Q51668560 | Reference values for respiratory pressures in a general adult population--results of the Study of Health in Pomerania (SHIP). |
| Q35794485 | Relationship between nutritional risk and exercise capacity in severe chronic obstructive pulmonary disease in male patients |
| Q36471113 | Relationship of obesity with respiratory symptoms and decreased functional capacity in adults without established COPD |
| Q36218050 | Research opportunities in the management of acute exacerbations of chronic obstructive pulmonary disease |
| Q34149538 | Respiratory muscle function and drive in chronic obstructive pulmonary disease. |
| Q35536372 | Respiratory muscle strength and the risk of incident cardiovascular events |
| Q88053432 | Respiratory muscles in COPD: be aware of the diaphragm |
| Q37017243 | Respiratory muscles training in COPD patients |
| Q35771480 | Reversal of chronic obstructive pulmonary disease-associated weight loss : are there pharmacological treatment options? |
| Q51570675 | Routine laboratory tests can predict in-hospital mortality in acute exacerbations of COPD. |
| Q74091755 | Screening method evaluated by nutritional status measurements can be used to detect malnourishment in chronic obstructive pulmonary disease |
| Q57631533 | Self-reported diabetes and mortality in a prospective Chinese elderly cohort study in Hong Kong |
| Q24792076 | Skeletal muscle dysfunction in chronic obstructive pulmonary disease |
| Q48085402 | Study of body composition, lung function, and quality of life following use of anabolic steroids in patients with chronic obstructive pulmonary disease |
| Q34286708 | Success in pulmonary rehabilitation in patients with chronic obstructive pulmonary disease |
| Q37070379 | Systemic impairment in relation to disease burden in patients with moderate COPD eligible for a lifestyle program. Findings from the INTERCOM trial |
| Q37340178 | Targeted treatment in COPD: a multi-system approach for a multi-system disease |
| Q60045570 | The BODE index and inspiratory muscle performance in COPD: Clinical findings and implications |
| Q47675984 | The Influence of Body Composition on Pulmonary Rehabilitation Outcomes in Chronic Obstructive Pulmonary Disease Patients. |
| Q37641193 | The impact of body mass index on inpatient- versus outpatient-treated chronic obstructive pulmonary disease exacerbations |
| Q37821008 | Therapeutic effects of anabolic androgenic steroids on chronic diseases associated with muscle wasting |
| Q52042440 | Total daily energy expenditure in wasted chronic obstructive pulmonary disease patients. |
| Q36714246 | Transplantation in chronic obstructive pulmonary disease |
| Q77784930 | [Function of respiratory muscles in malnutrition and in the critically ill patient] |
| Q57218094 | [Prevalence of malnutrition in outpatients with stable chronic obstructive pulmonary disease] |
| Q80133380 | [Prognostic factors in chronic obstructive pulmonary disease] |
| Q80781974 | [Risk factors for mortality in chronic obstructive pulmonary disease] |
Search more.